The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 26, 2019

Filed:

Nov. 30, 2013
Applicants:

University of Rochester, Rochester, NY (US);

Board of Regents of the University of Nebraska, Omaha, NE (US);

Inventors:

Harris A. Gelbard, Pittsford, NY (US);

Stephen Dewhurst, Rochester, NY (US);

Howard E. Gendelman, Omaha, NE (US);

Assignees:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/496 (2006.01); A61K 45/06 (2006.01); A61K 31/427 (2006.01); A61K 31/4418 (2006.01); A61K 9/48 (2006.01);
U.S. Cl.
CPC ...
A61K 31/496 (2013.01); A61K 9/4866 (2013.01); A61K 31/427 (2013.01); A61K 31/4418 (2013.01); A61K 45/06 (2013.01);
Abstract

Disclosed are methods for treating an individual infected with a retrovirus that comprise administering to the individual effective amounts of a mixed lineage kinase inhibitor and antiretroviral drug. In further aspects, disclosed are methods for treating an individual infected with a retrovirus that comprises administering an antiretroviral drug formulated into a crystalline nanoparticle comprising a surfactant, and a MLK inhibitor. Still further disclosed are methods for treating an individual infected with a retrovirus that comprises administering a composition comprising both an antiretroviral and MLK inhibitor formulated into a crystalline nanoparticle, which comprises a surfactant. Still further disclosed are compositions that comprise an antiretroviral drug, a MLK inhibitor, and a surfactant, wherein the composition is a crystalline nanoparticle. Compostions comprising MLK inhibitors with other drugs in nanoparticulate form, and methods of there use, are also disclosed.


Find Patent Forward Citations

Loading…